THERAPEUTIC CLASS

Safety of New Oral Anticoagulants for Patients with Chronic Kidney Disease

---

In daily practice, chemical substances called “direct oral anticoagulants” or DOACs are more convenient
to administer when set beside vitamin K antagonists (VKA) due to improved pharmacologic properties, fewer
drug interactions and rapid onset of action. The objective of this review was to assess whether DOACs are the
alternative for VKA in subjects with mild-to-moderate chronic kidney disease (CKD).

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

Therapeutic Class

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Cardiovascular & Hematopoietic System

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment